Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

NCT00022880 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Corixa Corporation

Collaborators